#111 - AMA #14: What lab tests can (and cannot) inform us about our overall objective of longevity

#111 - AMA #14: What lab tests can (and cannot) inform us about our overall objective of longevity

0 Calificaciones
0
Episodio
144 of 428
Duración
17min
Idioma
Inglés
Formato
Categoría
Crecimiento personal

In this "Ask Me Anything" (AMA) episode, Peter explains his framework for understanding what lab tests can (and cannot) inform us as it pertains to overall longevity, with a specific focus on atherosclerosis, cancer, Alzheimer's disease, and the physical body. Additionally, Peter shares details into two patient case studies around cardiovascular disease, including how the lab results influenced his diagnosis and treatment plan for the patients. Once again, Bob Kaplan, Peter's head of research, will be asking the questions. If you're not a subscriber and listening on a podcast player, you'll only be able to hear a preview of the AMA. If you're a subscriber, you can now listen to this full episode on your private RSS feed or on our website at the AMA #14 show notes page. We discuss: • Important lab tests and reference ranges [2:35]; • How lab testing fits into the overall objective of longevity [4:25]; • A healthcare system set up to react to a disease rather than prevent it [8:00]; • The four pillars of chronic disease, and the three components of healthspan [14:30]; • Atherosclerosis—How much can labs tell us about risk? [18:00]; • Coronary calcium score (CAC)—Interpreting results based on your age [24:15]; • Cancer—What lab work can tell you, and the future of liquid biopsies [28:00]; • Alzheimer's disease—What's driving Alzheimer's disease, and what labs can tell you about your risk [33:15]; • Healthspan and the physical body—Where lab testing fits, the endocrine system, and zone 2 testing [39:00]; • Summarizing the usefulness of lab testing—Where it gives great, reasonable, or lousy insight [43:15]; • Patient case study—Elevated Lp(a): Understanding ApoB, and how cholesterol levels get reduced [45:30]; • Patient case study—Familial hypercholesterolemia [59:30]; • Coming up on a future AMA [1:10:30]; and • More. Learn more: https://peterattiamd.com/ Show notes page for this episode: https://peterattiamd.com/ama14 Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ Connect with Peter on Facebook | Twitter | Instagram.


Escucha y lee

Descubre un mundo infinito de historias

  • Lee y escucha todo lo que quieras
  • Más de 1 millón de títulos
  • Títulos exclusivos + Storytel Originals
  • Precio regular: CLP 7,990 al mes
  • Cancela cuando quieras
Suscríbete ahora
Copy of Device Banner Block 894x1036 3
Cover for #111 - AMA #14: What lab tests can (and cannot) inform us about our overall objective of longevity

Otros podcasts que te pueden gustar...